Search Results 501-510 of 14839 for anti-TNF drugs

  1. Expanded Access Program With Nivolumab (BMS-936558) in Combination With Ipilimumab (Yervoy®) in Anti-CTLA-4 Treatment-Naïve Subjects With Unresectable or Metastatic Melanoma (CheckMate 218) - Mayo Clinic

    Expanded Access Program With Nivolumab (BMS-936558) in Combination With Ipilimumab (Yervoy®) in Anti-CTLA-4 Treatment-Naïve Subjects With Unresectable or ...

  2. Tobramycin And Dexamethasone (Ophthalmic Route) Description and Brand Names - Mayo Clinic

    Description and Brand Names. Drug information provided by: Merative, Micromedex®. US Brand Name. Tobradex; Tobradex ST. Canadian Brand Name.

  3. Fenfluramine (Oral Route) Description and Brand Names - Mayo Clinic

    Fenfluramine is used alone or with other medicines (eg, stiripentol, clobazam) to treat seizures in patients with Dravet syndrome (DS) and Lennox-Gastaut ...

  4. Thyrotropin Alfa (Intramuscular Route) Description and Brand Names - Mayo Clinic

    Description and Brand Names. Drug information provided by: Merative, Micromedex®. Descriptions. Thyrotropin alfa injection is a form of human thyroid ...

  5. A Study to Determine the Safety, Tolerability and Pharmacokinetics of an Anti-PD-1 Monoclonal Antibody in Subjects With Advanced Malignancies - Mayo Clinic

    A Study to Determine the Safety, Tolerability and Pharmacokinetics of an Anti-PD-1 Monoclonal Antibody in Subjects With Advanced Malignancies. Print details.

  6. Fluticasone (Nasal Route) Before Using - Mayo Clinic

    Weigh the potential benefits against the potential risks before taking this medication while breastfeeding. Drug Interactions. Although certain medicines should ...

  7. Pentostatin (Intravenous Route) Before Using - Mayo Clinic

    Weigh the potential benefits against the potential risks before taking this medication while breastfeeding. Drug Interactions. Although certain medicines should ...

  8. Drospirenone And Estetrol (Oral Route) Before Using - Mayo Clinic

    Weigh the potential benefits against the potential risks before taking this medication while breastfeeding. Drug Interactions. Although certain medicines should ...

  9. Fam-Trastuzumab Deruxtecan-Nxki (Intravenous Route) Description and Brand Names - Mayo Clinic

    ... anti-HER2 breast cancer treatment for metastatic disease or have breast cancer that has come back during or within 6 months of completing treatment for ...

  10. A Study to Evaluate the Safety and Effectiveness of BMS-986165 in Subjects with Moderate-to-Severe Ulcerative Colitis (UC) - Mayo Clinic

    Drugs & Supplements A-Z · Health Books · Healthy Living Program · Mayo Clinic ... anti-tumor necrosis factor (TNF)-α agents, integrin inhibitor. Exclusion ...